Correlation Between NexGel Warrant and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both NexGel Warrant and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NexGel Warrant and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NexGel Warrant and NLS Pharmaceutics AG, you can compare the effects of market volatilities on NexGel Warrant and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NexGel Warrant with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NexGel Warrant and NLS Pharmaceutics.
Diversification Opportunities for NexGel Warrant and NLS Pharmaceutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NexGel and NLS is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding NexGel Warrant and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and NexGel Warrant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NexGel Warrant are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of NexGel Warrant i.e., NexGel Warrant and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between NexGel Warrant and NLS Pharmaceutics
Assuming the 90 days horizon NexGel Warrant is expected to generate 4.56 times less return on investment than NLS Pharmaceutics. But when comparing it to its historical volatility, NexGel Warrant is 2.61 times less risky than NLS Pharmaceutics. It trades about 0.08 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 1.00 in NLS Pharmaceutics AG on October 25, 2024 and sell it today you would earn a total of 0.16 from holding NLS Pharmaceutics AG or generate 16.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.0% |
Values | Daily Returns |
NexGel Warrant vs. NLS Pharmaceutics AG
Performance |
Timeline |
NexGel Warrant |
NLS Pharmaceutics |
NexGel Warrant and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NexGel Warrant and NLS Pharmaceutics
The main advantage of trading using opposite NexGel Warrant and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NexGel Warrant position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.NexGel Warrant vs. Nexgel Inc | NexGel Warrant vs. NLS Pharmaceutics AG | NexGel Warrant vs. NeuroSense Therapeutics Ltd | NexGel Warrant vs. Cingulate Warrants |
NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |